Analysts Set DocGo Inc. (NASDAQ:DCGO) PT at $3.21

DocGo Inc. (NASDAQ:DCGO) has received an average recommendation of “Hold” from the seven brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $3.2125.

A number of analysts have commented on DCGO shares. Canaccord Genuity Group cut their price objective on shares of DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a report on Wednesday, November 12th. Zacks Research upgraded DocGo from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of DocGo in a research report on Monday, December 15th.

DocGo Price Performance

NASDAQ:DCGO opened at $0.93 on Thursday. The company has a 50 day moving average price of $1.03 and a 200-day moving average price of $1.33. DocGo has a 1-year low of $0.86 and a 1-year high of $5.68. The firm has a market cap of $90.64 million, a price-to-earnings ratio of -1.78 and a beta of 0.93.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings results on Monday, November 10th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.02). The business had revenue of $70.81 million for the quarter, compared to analysts’ expectations of $69.96 million. DocGo had a negative return on equity of 9.11% and a negative net margin of 14.02%. On average, sell-side analysts anticipate that DocGo will post 0.25 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. S Squared Technology LLC boosted its position in DocGo by 36.8% in the 1st quarter. S Squared Technology LLC now owns 1,890,976 shares of the company’s stock valued at $4,992,000 after buying an additional 508,590 shares during the last quarter. P.A.W. Capital Corp boosted its holdings in DocGo by 60.0% in the second quarter. P.A.W. Capital Corp now owns 3,200,000 shares of the company’s stock valued at $5,024,000 after purchasing an additional 1,200,000 shares during the last quarter. Punch & Associates Investment Management Inc. grew its stake in DocGo by 17.4% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 2,201,667 shares of the company’s stock valued at $5,812,000 after purchasing an additional 325,760 shares in the last quarter. Birchview Capital LP grew its stake in DocGo by 13.1% during the 1st quarter. Birchview Capital LP now owns 864,062 shares of the company’s stock valued at $2,281,000 after purchasing an additional 100,000 shares in the last quarter. Finally, Nuveen LLC purchased a new stake in DocGo during the 1st quarter worth approximately $649,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.